Close Menu

NEW YORK (GenomeWeb) – Qiagen said today that its Artus CMV QS-RGQ molecular diagnostic kit for use on the QiaSymphony platform has received premarket approval from the US Food and Drug Administration.

The real-time PCR assay is designed to be used with human plasma samples, and is intended to aid in the management of solid organ transplant patients who are undergoing anti-cytomegalovirus therapy.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.